A Brand New Kind of Schizophrenia Treatment
For the past 70 years, schizophrenia treatments all targeted the same chemical: dopamine. While that works for some, it causes brutal side effects for others. An antipsychotic drug approved last month by the FDA changes that. It triggers muscarinic receptors instead of dopamine receptors. The drug is the result of a…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
Similar episodes from other shows
More like Short Wave →
The New Hit Depression Treatment? A Ketamine-Derived Nasal Spray
Can Psychedelic Therapy Go Mainstream?
AI Is Coming Up With Brand New Molecules, Fueling Drug Discovery
The Video Game Treatment
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.